跳至主要内容
临床试验/CTRI/2020/10/028478
CTRI/2020/10/028478尚未招募3 期

Azithromycin as an add-on drug in children aged 5-14 years with acute exacerbation of asthma - Azipeds

I0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • children aged 5-14 years presenting with acute exacerbation of asthma

排除标准

  • 1.Children with heart ,liver ,neurological or kidney diseases.
  • 2.Children with evidence of pneumonia
  • 3.Children with respiratory rate more than 50, or fever more than 39 degree Celsius.
  • 4.Children with abnormal development of airways ,congenital respiratory tract diseases
  • 5.Children with metabolic and autoimmune diseases.
  • 6.Children with known Q-T interval prolongation
  • 7.Children with macrolide allergy
  • 8.Children taking medication which prolongs Q-T interval
  • 9.Children using oral and systemic antibiotic within 28 days of enrollment
  • 10.Children who needs intensive care
  • 11.Children with history of tachyarrhythmia and /or bradyarrhythmia
  • 12.Caregivers who are not willing to give informed written consent
  • 13.Children with recurrent chest infections

研究者

发起方
I

相似试验